Andersons pediatric cardiology 2336
Bạn đang xem bản rút gọn của tài liệu. Xem và tải ngay bản đầy đủ của tài liệu tại đây (79.68 KB, 3 trang )
valveformationand,46
ofarterialvalves,46
ofatrioventricularcanal,46
ofsinoatrialjunction,46
ofvenouscomponents,36–37,36f–38f
ventricularloopdevelopmentand,41–42,41f–42f
ventricularwallsformationand,46–47,47f
Cardiacfailure
chronic,fetalgenesand,85
geneticfactorsin,85
Cardiacfunction,withpressure-volumeloop,examinationof,1195–1196,
1195f–1196f
Cardiacintensivecareunit(CICU),1482t
Cardiacloop,formationof,34–35,34f
Cardiaclooping,inearlymyocardialdevelopment,59–60,60f
Cardiacmagneticresonance(CMR),317–332
3Dprinting,330–332,331f–332f
inarrhythmias,358
incancertherapy-relatedcardiotoxicity,1170
incardiomyopathies,geneticdiseases,acquiredcardiacdiseases,319t
contraindicationsto,328
ECGmonitoringof,328
environmentandpatientpreparation,327–328,327f
fetal,329–330,329f
generalanesthesiaorsedation,327–328
magneticresonanceimagingprotocolsandsequencesof,319–325,320t–321t
inmyocarditis,1175,1177f
postmortem,330,330f
postprocessingof,325,326f
forpulmonaryhypertension,1387–1388
quantificationofphysiologyof,325–327
radiationdoseoptimizationinchildren,333
recentdevelopmentin,328–332
safety,328
scannerandpatientpreparationof,327,327f
instructuralcongenitalheartdisease,318t
Cardiacmyocyte,cellularphysiologyof,1197–1198
Cardiacneurodevelopmentalprograms,forcomplexcongenitalcardiacdisease,
1402
Cardiacoutput,1264
developmentalchangesin,96
indiagnosticcatheterization,242
exerciseand,382
exercisetestingand,393,393t
myocardialdysfunctionwith,1179
surrogatesfor,exerciseand,383–384,384f
Cardiacresynchronizationtherapy(CRT),367,368f
forcancertherapy-relatedcardiotoxicity,1172
forchronicheartfailure,1201–1202
fordilatedcardiomyopathy,1159
Cardiacrhythm,evaluationof,exercisetestingfor,391
Cardiacsegments,embryologyof,35–36,35f–36f
Cardiacshunt,327
Cardiacsparing,fetal,95
Cardiacstatus,inKawasakisyndrome,994–995
Cardiacstretchreceptors,incontrolofcirculation,1358–1359
Cardiacsurgery
associatedAKI,long-termrenalconsequencesof,1425,1425t
onbrain,1397–1399,1398b
anesthesiain,1399
cardiopulmonarybypassstrategyin,1398–1399
hematocritduringbypass,1399
pHmanagementin,1399
Cardiactamponade,1073t
clinicalpresentationof,1066
investigationsfor,1066–1067,1066f–1067f
managementof,1067–1068,1068f
pathophysiologyof,1065–1066
Cardiactransplantation
ethicalissuesin,1475–1477
forKawasakisyndrome,992
formyocarditis,1177
Cardiactumors,963–977,964t
catheterizationin,968
chestradiographyin,966–967,967f
clinicalsignsandsymptomsof,963–966,965t
arrhythmias,965
cardiacfailureandpericardialeffusion,965,966f
cardiacmanifestationsand,964–965
embolicmanifestationsand,963–964,964f–965f
obstruction,965–966,966f
physicalexaminationin,966
systemicmanifestationsand,963
computedtomographyin,968,969f
definitionsof,963
echocardiographyin,967–968,967f–968f
electrocardiographyin,966
investigationsof,966–968
laboratorystudiesin,966
magneticresonanceimagingin,968,969f
primary,976
secondary,976
treatmentof
chemotherapy,977
hearttransplantationas,977
surgical,976–977
typesof,968–976
bloodcysts,975,975f
fibromas,971–972,972f
lipomas,974–975
myxomas,972–973,972f–973f
papillaryfibroelastoma,975
Purkinjecelltumors,975–976
rhabdomyomas,968–971,970f
